Latest Asx Company Filings News

Kairos Minerals has revealed a significant new gold discovery at its Mt York project in Western Australia, highlighted by a 53m intercept grading 1.45 g/t Au near Main Hill. This breakthrough could materially expand the project’s 1.4 million ounce resource base.

Gibb River Diamonds has received the crucial Mining Proposal Permit for its Neta Gold Prospect, setting the stage for mining operations to begin with equipment mobilisation planned for August 2025.

Great Boulder Resources has reported significant high-grade gold intersections extending the Ironbark deposit 180 metres south, with assays up to 39.5g/t Au, suggesting a substantial resource expansion potential.

Albion Resources has launched Phase 2 of its Reverse Circulation drilling at the Yandal West gold project, targeting multiple high-potential zones with fully funded exploration.

Charter Hall Long WALE REIT reported stable FY25 financials with a $5.5 billion portfolio and 99.9% occupancy, maintaining strong income security. The REIT projects modest growth in FY26 with a 6.1% distribution yield.

Charter Hall Long WALE REIT reported steady FY25 earnings with strong occupancy and a strategic shift toward government-leased assets, setting the stage for growth in FY26.

Charter Hall Long WALE REIT reports a $118.3 million statutory profit for FY25, reversing last year's heavy loss, while maintaining stable distributions and actively managing debt facilities.

BWP Group reported a strong $265.6 million net profit for FY2025, driven by property valuation gains and rental growth, while completing a major internalisation and lease reset transaction with Wesfarmers.

REA Group Ltd reported a robust FY25 with 15% revenue growth to $1.673 billion and a 23% rise in net profit, driven by strong Australian market performance and strategic AI investments. The company also advanced its India operations, focusing on Housing.com amid PropTiger divestment plans.

REA Group has reported a robust FY25 with strong revenue and profit growth, underpinned by solid Australian market performance and strategic moves in India. The company also announced a leadership transition amid optimistic FY26 guidance.

Mayne Pharma has firmly rejected a fresh termination notice from Cosette Pharmaceuticals alleging breaches related to FDA disclosure, escalating an ongoing contractual dispute with significant legal implications.

Vmoto reports a sharp 44% decline in 2Q25 sales driven by China’s slowdown but counters with strategic UK investment and a new Uber partnership to electrify European delivery fleets.